RVMD ▼ -0.8% - Revolution Medicines, Inc.
$RVMD - Revolution Medicines’ RASONQUE(™) (daraxonrasib) Receives Positive CHMP Opinion Recommending Marketing Authorization in European Union for Metastatic Pancreatic Cancer
15-OCT-2026 09:45 AM ET
Share this post
More filings for $RVMD
RVMD ▼ -6.3% - Revolution Medicines, Inc.Oct 8, 2026RVMD ▼ -6.3% - Revolution Medicines, Inc.Oct 8, 2026RVMD ▲ +0.4% - Revolution Medicines, Inc.Oct 5, 2026RVMD ▼ -0.6% - Revolution Medicines, Inc.Sep 15, 2026RVMD ▼ -1.5% - Revolution Medicines, Inc.Sep 14, 2026RVMD ▲ +1.0% - Revolution Medicines, Inc.Sep 10, 2026
View full $RVMD filing history →💬 Comments
Loading comments…
Leave a comment